Erasca, Inc. (ERAS)
NASDAQ: ERAS · Real-Time Price · USD
19.11
-0.23 (-1.19%)
At close: Jul 24, 2026, 4:00 PM EDT
19.00
-0.11 (-0.58%)
After-hours: Jul 24, 2026, 7:37 PM EDT
Erasca Employees
Erasca had 103 employees as of December 31, 2025. The number of employees did not change compared to the previous year.
Employees
103
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$2,689,515
Market Cap
6.63B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 103 | 0 | - |
| Dec 31, 2024 | 103 | -23 | -18.25% |
| Dec 31, 2023 | 126 | -3 | -2.33% |
| Dec 31, 2022 | 129 | 6 | 4.88% |
| Dec 31, 2021 | 123 | 21 | 20.59% |
| Jun 30, 2021 | 102 | - | - |
| Mar 31, 2021 | 102 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| PTC Therapeutics | 991 |
| ImmunityBio | 691 |
| Mirum Pharmaceuticals | 418 |
| Rhythm Pharmaceuticals | 414 |
| Xenon Pharmaceuticals | 370 |
| Scholar Rock Holding | 289 |
| Cogent Biosciences | 258 |
| CG Oncology | 142 |
ERAS News
- 2 days ago - Kaplan Fox Reminds Erasca, Inc. (ERAS) Investors Seeking Recovery of the Lead Plaintiff Deadline on August 10, 2026 - Newsfile Corp
- 6 days ago - Erasca price target raised to $21 from $12 at Morgan Stanley - TheFly
- 11 days ago - Erasca Announces Closing of Upsized Public Offering of Common Stock, Including Full Exercise of Underwriters' Option to Purchase Additional Shares - GlobeNewsWire
- 12 days ago - Erasca price target raised to $24 from $21 at Jefferies - TheFly
- 12 days ago - Erasca 31.429M share Spot Secondary priced at $17.50 - TheFly
- 12 days ago - SueWallSt Reminds Shareholders of a Lead Plaintiff Deadline of August 10, 2026 in Erasca, Inc. Lawsuit - ERAS - GlobeNewsWire
- 12 days ago - Erasca price target raised to $18 from $16 at BofA - TheFly
- 13 days ago - Erasca Announces Pricing of Upsized Public Offering of Common Stock - GlobeNewsWire